Whole‐body magnetic resonance imaging plus serological follow‐up for early identification of progression in smouldering myeloma patients to prevent development of end‐organ damage-Reference-Cited by-同舟云学术

Whole‐body magnetic resonance imaging plus serological follow‐up for early identification of progression in smouldering myeloma patients to prevent development of end‐organ damage

Published:2022-05-24 Issue:1 Volume:199 Page:65-75
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Wennmann Markus¹^ORCID,Goldschmidt Hartmut²³,Mosebach Jennifer¹,Hielscher Thomas⁴,Bäuerle Tobias⁵,Komljenovic Dorde⁶,McCarthy Philip L.⁷,Merz Maximilian²⁷,Schlemmer Heinz‐Peter¹,Raab Marc‐Steffen²^ORCID,Sauer Sandra²,Delorme Stefan¹,Hillengass Jens⁷

Affiliation:

1. Division of Radiology German Cancer Research Center (DKFZ) Heidelberg Germany

2. Multiple Myeloma Section, Department of Medicine V University Hospital Heidelberg Heidelberg Germany

3. National Center for Tumor Diseases (NCT) University Hospital Heidelberg Heidelberg Germany

4. Division of Biostatistics German Cancer Research Center (DKFZ) Heidelberg Germany

5. Institute of Radiology Friedrich‐Alexander‐University Erlangen‐Nuremberg (FAU) and University Hospital Erlangen Erlangen Germany

6. Division of Medical Physics in Radiology German Cancer Research Center (DKFZ) Heidelberg Germany

7. Department of Medicine Roswell Park Comprehensive Cancer Center Buffalo New York USA

Funder

Deutsche Forschungsgemeinschaft

Dietmar Hopp Stiftung

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18232

Reference41 articles.

1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

2. Diagnosis of Smoldering Multiple Myeloma

3. Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease

4. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

5. Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinician preferences on treatment of smoldering myeloma: a cross-sectional survey;eClinicalMedicine;2023-11

2. Identification of focal lesion characteristics in MRI which indicate presence of corresponding osteolytic lesion in CT in patients with multiple myeloma;Bone;2023-10

3. Is aggressive treatment of smoldering myeloma the path to curing myeloma?;Blood Advances;2023-07-27

4. Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial;Cancers;2023-06-25

5. How do we image patients with multiple myeloma and precursor states?;British Journal of Haematology;2023-05-22